Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why You Should Hold Your Bets On the St. Jude Medical, Inc. (STJ) and Thoratec Corporation (THOR) Merger

Page 1 of 2

St. Jude Medical, Inc. (NYSE:STJrecently made a buyout offer for Thoratec Corporation (NASDAQ:THOR) to the tune of $3.4 billion. The purchase price offered a 10% premium on Thoratec’s closing stock price prior to the announcement of the offer. The smaller of the two hearing device makers, Thoratec Corporation (NASDAQ:THOR) is open to rival offers for the next 30 days under the terms of the agreement. In the event that the deal goes through, it is expected that it will close in the fourth quarter. The main catalyst for the deal could possibly be the approval that Thoratec Corporation (NASDAQ:THOR) received this month for the sale of its HeartMate PHP device in Europe, which the company intends to release later this year. Given this development we can question the fairness of the mere 10% premium, which is exactly what WeissLaw LLP, a national class action shareholder rights firm is investigating. The firm is ensuring that the definitive agreement is bereft of any breaches in fiduciary duty and that the Directors acted in the best interest of the shareholders.

Tarchyshnik Andrei/

Tarchyshnik Andrei/

The smart money has generally been bullish about the prospects of St. Jude Medical, Inc. (NYSE:STJ). During the first quarter the number of funds among those that we track, invested in the company increased to 37, with an aggregate investment of $630.79 million, compared to 33 funds with $523.32 million in shares held at the end of the previous quarter. The stock price climbed by about 2.8% in the same period.

At Insider Monkey, we track hedge funds’ moves in order to identify actionable patterns and profit from them. Our research has shown that hedge funds’ large-cap stock picks historically underperformed the S&P 500 Total Return Index by an average of seven basis points per month between 1999 and 2012. On the other hand, the 15 most popular small-cap stocks among hedge funds outperformed the S&P 500 Index by an average of 95 basis points per month (read the details here). Since the official launch of our small-cap strategy in August 2012, it has performed just as predicted, returning over 139% and beating the market by more than 80 percentage points. We believe the data is clear: investors will be better off by focusing on small-cap stocks utilizing hedge fund expertise (while avoiding their high fees at the same time) rather than large-cap stocks.

As far as insider trading surrounding St. Jude Medical, Inc. (NYSE:STJ) is concerned, no insider purchases have been detected so far this year, while prominent insider sales include those made by CEO Daniel Starks, who disposed of about 100,000 shares in April, and by Vice President Jeff Fecho, who has liquidated about 14,000 shares this year. It should be duly noted that insider sales are not as strong a signal as insider purchases since they can occur due to a wide variety of reasons and not just a bearish outlook.

Now let us take a closer look at whch particular segments in the hedge fund industry have been exuberant about St. Jude Medical, Inc. (NYSE:STJ).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!